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Chinese University of Hong Kong, Hong Kong, China.Figure 1 Air thrombi formed in the bottle of left atrial appendage (LAA) during the procedure of transcatheter LAA closure. A: A preprocedural
transesophageal echocardiogram indicated a windsock-like LAA (white arrow) with no thrombi, sludge, or spontaneous echocardiographic contrast. B: The ﬁrst
ﬂuoroscopy of the LAA showed no thrombus in the LAA. C: Thick air thrombi (black arrow) formed in the bottom of the LAA during the transcatheter LAA
closure. D: The subsequent LAA radiogram also showed the presence of a large ﬁlling defect in the bottom of the LAA. LA ¼ left atrium.
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Left atrial appendage (LAA) closure is an alternative
therapy for the patients with non-valvular atrial ﬁbrillation.
However, several complications were reported in the
procedure. We reported a classic image of air emboli
formed unexpectedly during the procedure of trans-
catheter LAA closure, which was closed using a LAmbre
occulder.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.03.015
KEY TEACHING POINTS
 LAmbre is a newly designed 2-disc closure device
for transcatheter left atrial appendage (LAA)
closure.
 Although the procedure of transcatheter LAA
closure has a higher rate of air thromboembolism
than routine interventional procedures like
percutaneous coronary intervention or closure of
atrial septal defect/ventricular septal defect, this is
the ﬁrst reported that was limited to the LAA with
excellent images of both transesophageal
echocardiogram and ﬂuoroscopy.
 The iatrogenic air embolus of this case was due to
the faulty use of a pressure infusion bag with the
500-mm bag of saline, which was wrapped by the
former. A small but practical tip for prevention of a
similar error is to use the pressure infusion bag
with 1000-mm bag of saline.
 The presence of embolus in the LAA is one of the
contraindications for transcatheter LAA closure
using WATCHMAN, but not the LAmbre.
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An 80-year-old Chinese woman with permanent atrial
ﬁbrillation was referred for transcatheter left atrial appendage
(LAA) closure using LAmbre (Lifetech Scientiﬁc Co,
Shenzhen, China), a new-generation double-disc closuredevice.1,2 The patient had a history of hypertension and 1
event of ischemic stroke, with a CHADS2 score of 4. She
was reluctant to receive warfarin because of the inconven-
ience of medical surveillance. Before the procedure, a
transesophageal echocardiogram (TEE) revealed a
windsock-like LAA3,4 with no presence of thrombi or sludge
(Figure 1A; Video 1, available online). The procedure was
conducted under general anesthesia. LAA was measured
through multiview ﬂuoroscopy (Figure 1B; Video 2, avail-
able online) and monitoring TEE to select the appropriate
size of the closure, which would be used to seal the oriﬁce of
the LAA subsequently. Unexpectedly, a tube of air was
accidentally injected into the LAA from the delivery sheath
because it was not noticed that the empty 500-mm bag
of saline was wrapped by the pressure infusion bag
(Supplementary Figure 1). Very quickly, thick air thrombi
formed in the bottom of the LAA (Figure 1C and D; Videos 3
and 4, available online). Then, a quick implantation of
LAmbre was conducted. The ﬁxed disc was anchored in
the landing zone (Figure 2A and B; Videos 5 and 6, available
online) prior to the deployment of the sealing disc (Video 7,
available online). After the unsheathing of the LAmbre
implanter with the delivery sheath, a ﬂuoroscopy showed
good location and sealing effect (Figure 2C; Video 8,
available online). TEE showed no residual shunt around
the device (Figure 2D; Video 9, available online). There
were no electrocardiogram changes or symptoms or signs of
stroke during the procedure. The patient underwent an
uneventful recovery and was discharged 3 days after the
procedure. Three-month routine TEE showed complete
sealing of the LAA (Figure 2E; Video 10, available online).
Figure 2 Transcatheter left atrial appendage (LAA) closure with LAmbre was conducted to seal the LAA and the thrombi. A: The ﬁxed disc (white arrow) of
the LAmbre device was quickly released and anchored in the landing zone. B: The monitoring transesophageal echocardiogram (TEE) revealed good location of
the ﬁxed disc. C: A transcatheter angiogram showed no obvious residual ﬂow around the device after the total deployment of the LAmbre implanter. D: The
monitoring TEE revealed good performance of the LAmbre device (white arrow). E: Three-month follow-up TEE showed good sealing of LAA closure and no
residual shunt around the device. LA ¼ left atrium.
Heart Rhythm Case Reports, Vol 2, No 6, November 2016458At present, there has been no recurrence of stroke or any
severe adverse event in this patient after 7-month follow-up.
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Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrcr.2015.
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